Skip to main content
. Author manuscript; available in PMC: 2011 Aug 4.
Published in final edited form as: Med Chem. 2008 Jan;4(1):75–79. doi: 10.2174/157340608783331443

Table 1.

Possible Mechanisms for HIV Protease Inhibitor Mediating Apoptosis

Theories Evidence
Alter caspase activity HIV PIs block Fas and TNF mediated apoptosis
HIV PIs not block caspase -1, -3, -4, -5, -6, -7, -8, or -9 activity in cell models
Inhibit Calpain activity HIV PIs inhibit apoptosis in cell systems where calpains are activated
HIV PIs blocked m-calpain activation in U937 cells
HIV PIs inhibited activity of both m- and -μ calpain isoforms in PC12 cells
HIV PI did not inhibit m- or μ-calpain hydrolysis or activation at lower, physiologic, concentrations
Alter levels of apoptosis regulatory proteins No change in Fas protein levels after HIV PI treatment
No change in RNA levels of Fas, Fas L, and TNF after HIV PI treatment
No change in Bcl-2, Bax, and Bcl-XL after HIV PI treatment
Maintain Mitochondrial Transmembrane Potential HIV PIs maintain mitochondrial membrane integrity after apoptosis stimuli
HIV PIs prevent cytochrome c release from mitochondria after apoptosis stimuli
ANT (adenine nucleotide translocator) necessary for HIV PI to block mitochondria mediated apoptosis